Teriparatide 20mcg Injection — Parathyroid Hormone Analogue for Severe Osteoporosis
Terifrac® (Teriparatide) — Anabolic Bone-Building Treatment for Osteoporosis
Affordable Teriparatide Option for Severe Osteoporosis Management
Terifrac® (Teriparatide) is a recombinant human parathyroid hormone analogue used to treat severe osteoporosis in postmenopausal women, men with osteoporosis, and patients with glucocorticoid-induced osteoporosis at high risk of fracture. Terifrac contains the same active ingredient as Forteo — Teriparatide 20mcg — and works through the same anabolic bone-building mechanism.
A.K. Pharma is a trusted medicine distributor in Delhi supplying genuine Terifrac (Teriparatide) to hospitals, orthopaedic centres, endocrinology clinics, and pharmacies across India. Terifrac offers an accessible alternative to branded Teriparatide therapies for patients requiring anabolic osteoporosis treatment.
What is Terifrac (Teriparatide)?
Terifrac contains Teriparatide, a 34 amino acid recombinant fragment of human parathyroid hormone (PTH 1-34). When administered as a once-daily subcutaneous injection, Teriparatide stimulates osteoblast-mediated bone formation, increasing bone mineral density and improving bone microarchitecture — reducing fracture risk in high-risk patients.
Teriparatide is the only class of osteoporosis treatment that works anabolically — building new bone — rather than simply preventing bone loss. This makes it particularly valuable in patients with severely compromised bone mass where antiresorptive therapy alone is insufficient.
Full prescribing information is available at the FDA label for Teriparatide.
Clinical Studies and Evidence
Terifrac contains the same active ingredient as Forteo (Teriparatide) and shares the same clinical evidence base.
Fracture Prevention Trial (FPT) Published in the New England Journal of Medicine (2001), the pivotal FPT demonstrated Teriparatide reduced vertebral fractures by 65% and non-vertebral fragility fractures by 53% compared to placebo in postmenopausal women with osteoporosis over 21 months.
VERO Trial (Teriparatide vs Risedronate) Published in The Lancet (2017), the VERO trial demonstrated Teriparatide reduced new vertebral fractures by 56% compared to Risedronate in postmenopausal women with severe osteoporosis — the first head-to-head fracture outcomes trial of an anabolic vs antiresorptive treatment.
Glucocorticoid-Induced Osteoporosis Trial Published in the New England Journal of Medicine (2007), Teriparatide demonstrated superior efficacy compared to Alendronate in increasing lumbar spine BMD and reducing vertebral fractures in glucocorticoid-induced osteoporosis.
Real-World Evidence Multiple real-world studies including the European Forsteo Observational Study (EFOS) have confirmed Teriparatide’s effectiveness in reducing fractures in osteoporosis patients in routine clinical practice.
Available Strengths
Terifrac is available as:
The recommended dose is 20mcg subcutaneously once daily. Maximum treatment duration is 24 months over a lifetime. After completing Terifrac treatment patients should transition to antiresorptive therapy to consolidate bone density gains.
Indications — What Terifrac is Used For
For detailed indication information refer to MedlinePlus Teriparatide.
Key Benefits of Terifrac
Same Active Ingredient as Forteo Terifrac contains the same Teriparatide 20mcg active ingredient as the originator brand Forteo, with the same mechanism of action and clinical effectiveness.
Anabolic Bone Formation Unlike antiresorptive agents that slow bone loss, Terifrac actively builds new bone — increasing bone mineral density, improving bone microarchitecture, and reducing fracture risk.
Proven Fracture Reduction Teriparatide reduces vertebral fractures by 65% and non-vertebral fractures by 53% based on the pivotal FPT clinical trial data.
Effective in Treatment-Resistant Cases Terifrac is particularly valuable in patients who have continued to fracture despite antiresorptive therapy, offering a fundamentally different mechanism of action.
Accessible Alternative Terifrac provides an accessible option for patients requiring Teriparatide therapy, making anabolic osteoporosis treatment available to a broader patient population.
How Terifrac Works
Terifrac works through the same mechanism as all Teriparatide formulations:
For a detailed mechanism overview refer to the International Osteoporosis Foundation and the American Society for Bone and Mineral Research.
Terifrac vs Forteo — Comparison
| Feature | Terifrac (Teriparatide) | Forteo (Teriparatide) |
|---|---|---|
| Active Ingredient | Teriparatide 20mcg | Teriparatide 20mcg |
| Mechanism | Anabolic bone building | Anabolic bone building |
| Dose | 20mcg once daily | 20mcg once daily |
| Treatment Duration | Maximum 24 months | Maximum 24 months |
| Administration | Subcutaneous injection | Subcutaneous injection |
| Manufacturer | Sun Pharma/Cipla | Eli Lilly |
| Available at A.K. Pharma | Request Quote | Request Quote |
Dosage and Administration
Full dosing guidelines available at Drugs.com Teriparatide Dosage.
Who Should Use Terifrac
Terifrac is prescribed for:
Terifrac is prescribed by endocrinologists, orthopaedic surgeons, rheumatologists, and general physicians. A.K. Pharma supplies Terifrac to hospitals, orthopaedic centres, and pharmacies across Delhi and India.
Possible Side Effects
Common side effects include nausea, headache, dizziness, leg cramps, fatigue, and injection site reactions such as pain and bruising. Transient hypercalcaemia may occur after injection and typically resolves within a few hours.
Serious side effects include:
Full side effect information available at FDA Teriparatide Safety Information.
Precautions and Contraindications
Terifrac is contraindicated in:
Additional precautions:
Storage and Handling
As a responsible medicine distributor in Delhi, A.K. Pharma maintains strict cold chain requirements throughout storage and supply of Terifrac, ensuring full product integrity for every unit supplied to hospitals and pharmacies.
Manufacturer Information
Terifrac (Teriparatide) is manufactured by Sun Pharma or Cipla — leading Indian pharmaceutical companies committed to producing high quality specialty medicines. A.K. Pharma supplies only genuine Terifrac sourced from authorized distributors, ensuring product authenticity and efficacy for every order.
Osteoporosis Treatment Sequence — How Terifrac Fits
Osteoporosis management typically follows a sequential treatment approach:
This sequential approach is supported by the International Osteoporosis Foundation treatment guidelines.
Related Bone Medicines Available at A.K. Pharma
Frequently Asked Questions
Q. What is Terifrac used for? Terifrac (Teriparatide) is used to treat severe osteoporosis in postmenopausal women, men with osteoporosis, and patients with glucocorticoid-induced osteoporosis at high risk of fracture. More information available at MedlinePlus.
Q. What is the difference between Terifrac and Forteo? Both Terifrac and Forteo contain the same active ingredient — Teriparatide 20mcg — and have the same mechanism of action, efficacy, and safety profile. They are different brands of the same medicine. A.K. Pharma supplies both — contact us for current availability and pricing.
Q. How long should Terifrac be used? The maximum treatment duration for Terifrac is 24 months over a lifetime. It should not be re-administered after completing the 24-month course. After completing treatment patients should be transitioned to antiresorptive therapy.
Q. What happens after stopping Terifrac? After completing the 24-month Terifrac course patients should be transitioned to antiresorptive therapy such as Prolia (Denosumab) or bisphosphonates to consolidate and maintain the bone mineral density gains achieved during treatment.
Q. Is Terifrac available in India? Terifrac can be supplied to hospitals, orthopaedic centres, and pharmacies across India through licensed pharmaceutical distributors. Contact A.K. Pharma — medicine distributor in Delhi — for availability and pricing.
Q. What is the price of Terifrac in India? Terifrac price in India varies by pack size. Contact A.K. Pharma at 011 4172 6999 or WhatsApp +91 9810034827 for current pricing and bulk supply rates.
Q. How to order Terifrac from A.K. Pharma? You can request a quote directly from this page, call us at 011 4172 6999, or WhatsApp us at +91 9810034827 with your requirements and we will respond promptly.
Q. Does A.K. Pharma supply Terifrac in bulk? Yes. A.K. Pharma supplies Terifrac in bulk to hospitals, orthopaedic centres, endocrinology clinics, and pharmacies across Delhi and India. Contact us for bulk pricing and availability.
Why Order Terifrac from A.K. Pharma?
Contact A.K. Pharma for Terifrac Supply 📍 E-2/257A, 2nd Floor, Shastri Nagar, New Delhi 110052 📞 011 4172 6999 📱 WhatsApp: +91 9810034827 🌐 akpharma.in
